These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3263521)

  • 1. [Studies on the mechanism of liver injury by lymphokine-activated killer cell].
    Mizoguchi Y; Kondo Y; Kodama C; Sakagami Y; Seki S; Kobayashi K; Yamamoto S; Morisawa S
    Nihon Shokakibyo Gakkai Zasshi; 1988 Jul; 85(7):1390-7. PubMed ID: 3263521
    [No Abstract]   [Full Text] [Related]  

  • 2. [Augmentation of lymphokine-activated killer (LAK) cell activity by combination of low dose interleukin 2 and several kinds of biological response modifiers (BRMs)].
    Ohnishi H; Okuno K; Nakamura T; Nakamura Y; Yasutomi M
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2539-45. PubMed ID: 3264846
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of lymphokine-activated killer activity in childhood acute lymphoblastic leukemia.
    Kato M
    Acta Paediatr Jpn; 1987 Apr; 29(2):206-13. PubMed ID: 3150903
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients.
    Boyer PJ; Berek JS; Zighelboim J
    Obstet Gynecol; 1989 May; 73(5 Pt 1):793-7. PubMed ID: 2784847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ultraviolet B irradiation on human natural killer cell and lymphokine activated killer cell activity: therapeutic potential in bone marrow transplantation and tumor immunotherapy.
    Yaron I; Zakheim AR; Oluwole SF; Hardy MA
    Transplant Proc; 1995 Feb; 27(1):1379. PubMed ID: 7878918
    [No Abstract]   [Full Text] [Related]  

  • 6. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
    Brooks B; Rees RC
    Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of inositol phosphates during triggering of cytotoxicity in human natural killer and lymphokine-activated killer cells.
    Ståhls AK; Carpén O
    Scand J Immunol; 1989 Feb; 29(2):211-6. PubMed ID: 2784224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine-activated killer (LAK) cell phenomenon in cluster headache. "In vitro" activation by recombinant interleukin-2.
    Giacovazzo M; Stirparo G; DeStefano L; Martelletti P; Rinaldi-Garaci C
    Headache; 1989 Mar; 29(3):177-9. PubMed ID: 2785095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of lymphokine-activated killer cells from non-Hodgkin's lymphoma patients.
    Jhaver KG; Advani SH; Nadkarni JJ
    Immunol Lett; 1990 Jun; 24(3):217-23. PubMed ID: 2384264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low susceptibility of choriocarcinoma cell lines to lymphokine activated killer (LAK) cells].
    Kameda T; Negoro T; Hagiwara M; Koyama M; Matsuzaki N; Saji F; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):1-6. PubMed ID: 2784473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of human peripheral blood lymphocytes cultured with recombinant interleukin 2].
    Morita T; Minato N; Tokue A; Yonese Y
    Nihon Hinyokika Gakkai Zasshi; 1988 May; 79(5):780-7. PubMed ID: 3266267
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes.
    Whiteside TL; Heo DS; Takagi S; Herberman RB
    Immunol Ser; 1989; 48():139-57. PubMed ID: 2488318
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells.
    Melder RJ; Balachandran R; Rinaldo CR; Gupta P; Whiteside TL; Herberman RB
    AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1011-5. PubMed ID: 2223237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 and lymphokine-activated killer cells in the treatment of childhood primary hepatocellular carcinoma--a preliminary report.
    Hsieh KH; Chang JS; Wu HL; Chu CT
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):13-6. PubMed ID: 3040030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.
    Fisher RI; Coltman CA; Doroshow JH; Rayner AA; Hawkins MJ; Mier JW; Wiernik P; McMannis JD; Weiss GR; Margolin KA
    Ann Intern Med; 1988 Apr; 108(4):518-23. PubMed ID: 3258138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors.
    Schwarz RE; Iwatsuki S; Herberman RB; Whiteside TL
    Hepatology; 1989 Aug; 10(2):221-7. PubMed ID: 2787271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant interferon-gamma and interleukin-2 on the generation of lymphokine-activated killer cells in vitro.
    Findley HW; Nasr S; Afify Z; Hnath R; Waldrep K; Ragab AH
    Cancer Invest; 1990; 8(5):493-500. PubMed ID: 2124946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma.
    Shirai M; Watanabe S; Nishioka M
    Hepatogastroenterology; 1990 Oct; 37(5):465-8. PubMed ID: 2174825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor antigen-independent effector mechanisms of graft rejection: a novel cell surface target of IL-2-activated natural killer cells.
    Norin AJ; Brewer RJ; Lui Q; Del Rio MJ; Burack J; Kamholz SL
    Transplant Proc; 1999; 31(1-2):787-8. PubMed ID: 10083337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.